CSPC Innovation Pharmaceutical Co., Ltd.

Shenzhen Stock Exchange 300765.SZ

CSPC Innovation Pharmaceutical Co., Ltd. Revenue for the year ending December 31, 2023: USD 352.36 M

CSPC Innovation Pharmaceutical Co., Ltd. Revenue is USD 352.36 M for the year ending December 31, 2023, a -7.42% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.

CSPC Innovation Pharmaceutical Co., Ltd. Revenue for the year ending December 31, 2022 was USD 380.60 M, a 68.88% change year over year.
CSPC Innovation Pharmaceutical Co., Ltd. Revenue for the year ending December 31, 2021 was USD 225.37 M, a 11.66% change year over year.
CSPC Innovation Pharmaceutical Co., Ltd. Revenue for the year ending December 31, 2020 was USD 201.83 M, a 11.86% change year over year.
CSPC Innovation Pharmaceutical Co., Ltd. Revenue for the year ending December 31, 2019 was USD 180.43 M, a 0.07% change year over year.

Key data

Date	Revenue	Gross Profit	Operating Income	EBIT

Shenzhen Stock Exchange: 300765.SZ

CSPC Innovation Pharmaceutical Co., Ltd.

CEO	Mr. Feng Han
IPO Date	March 22, 2019
Location	China
Headquarters	No. 36, Fuqiang Western Road
Employees	1,887
Sector	Consumers Staples
Industries Non-Alcoholic Beverages Alcoholic Beverages Consumer Packaged Goods Drugstores & Retail Pharmacies Pharmaceuticals Soft Drinks & Sodas Tobacco

Description

CSPC Innovation Pharmaceutical Co., Ltd. manufactures and sells caffeine, and vitamin C health supplement and beverage products. The company is based in Shijiazhuang, China. CSPC Innovation Pharmaceutical Co., Ltd. is a subsidiary of CSPC Pharmaceutical Group Limited.

Key trends

Past 5 years